StonvexLoading…
StonvexStonvexStonvexCore line items from SER's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $130.00K | $56.00K | $3.15M | $34.00K |
Operating Income | $-24.02M | $-17.05M | $-3.13M | $-6.97M |
Net Income | $-19.18M | $-11.14M | $5.27M | $-10.46M |
EPS (Diluted) | $-1.91 | $-1.51 | $0.73 | $-9.70 |
Total Assets | $6.95M | $6.72M | $8.97M | $3.24M |
Total Liabilities | $6.99M | $6.22M | $4.86M | $20.56M |
Cash & Equivalents | $3.06M | $3.67M | $7.62M | $645.00K |
Free Cash Flow OCF − CapEx | $-18.01M | $-17.16M | $-2.98M | Not available |
Shares Outstanding | 10.77M | 9.42M | 2.41M | 1.08M |